Merck’s commitment to continue its presence in Iran

Author:
Actoverco
Date:
21 April 2019
11

Paolo Carly’s speech, General Manager of German Merck Company in the Middle East and North Africa at the inauguration of the new Actoverco Solid Drug Production Plant (Actoverco 2)

Paolo Carly’s speech, General Manager of German Merck Company in the Middle East and North Africa at the inauguration of the new Actoverco Solid Drug Production Plant (Actoverco 2):

According to Actoverco’s Public Relations, Paolo Carly said: “We are committed to not stop our activities in Iran.”

We also request from the Iranian Ministry of Health to be consistent in its policies. We are just at the beginning of cooperation with Actoverco, and the level of cooperation between Merck and Actoverco will increase in the fields of chemical and biotech drugs.

Reference: PHANA

Related Posts

عید فطر - تلگرام - انگلیسی -04

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

4R4A68781-2048x1365

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

4R4A061511-2048x1365

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

4R4A3160

Holding the 21st MS Congress of Iran with the participation of Actoverco